BioCentury
ARTICLE | Finance

Euro IPOs

Europe uptick in biotech IPOs: Median; Moberg; Agendia

May 23, 2011 7:00 AM UTC

French cancer diagnostic play Median Technologies Inc. and Swedish dermatology company Moberg Derma AB completed IPOs last week, while Dutch molecular diagnostic company Agendia B.V. added itself to the queue.

Median raised €10 million ($14.1 million) through the private placement of 1.2 million shares at €8.05 in an IPO on NYSE Alternext Paris. The price values the company at €45 million ($63.6 million)...